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Summary 
Detecting gastrointestinal infection transmission among men who have sex with men 
(MSM) in England is complicated by a lack of routine sexual behavioural data. We 
investigated whether gender distributions might generate signals for increased 
transmission of gastrointestinal pathogens among MSM. We examined the 
percentage male of laboratory confirmed patient-episodes for patients with no known 
travel history for 10 gastrointestinal infections of public health interest in England 
between 2003 and 2013, stratified by age and region. An adult male excess was 
observed for Shigella spp. (annual maximum 71% male); most pronounced for those 
aged 25-49 years and living in London, Brighton and Manchester. An adult male 
excess was observed every year for Entamoeba histolytica (range 59.8-76.1% 
male), giardia (53.1-57.6%) and campylobacter (52.1-53.5%) and for a minority of 
years for hepatitis A (max. 69.8%) and typhoidal salmonella (max. 65.7%). This 
approach generated a signal for excess male episodes for six gastrointestinal 
pathogens, including a characterised outbreak of shigella among MSM. Stratified 
analyses by geography and age group were consistent with MSM transmission for 
shigella. Optimisation and routine application of this technique by public health 
authorities elsewhere might help identify potential gastrointestinal infection outbreaks 
due to sexual transmission among MSM, for further investigation.  
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Introduction 
Gastrointestinal (GI) pathogens including shigella [1, 2], campylobacter [3, 4], vero 
cytotoxin-producing Escherichia coli (VTEC) [5], giardia [6, 7], Salmonella enterica
serotype Typhi [8], cryptosporidium [9, 10], hepatitis A [11-14] and enteric 
protozoans, including Entamoeba histolytica [15], can be spread through sexual 
contact, most commonly among men who have sex with men (MSM)[16]. Risk of 
infection is likely influenced by sexual practices, infectivity and HIV status [16, 17].   
In England, sexual history is not routinely collected for most cases of laboratory 
confirmed gastrointestinal infections reported to Public Health England (PHE). In the 
absence of this information, there is the risk that increases or outbreaks among MSM 
may go undetected. However, increased transmission of GI infections among MSM 
might produce a detectable signal in the gender distribution among cases reported in 
routine surveillance data. Gender ratios have been applied previously to 
demonstrate that HIV infection was transmitted predominantly between 
heterosexuals in Africa in the 1980’s [18] and as a surrogate marker for MSM activity 
in Atlanta, USA [6].  
A rise in Shigella flexneri 3a in England has been described among men without a 
known history of recent travel from 2009. Follow-up of a sub-set of cases suggested 
that faecal-oral transmission occurred during sexual contact between MSM, many of 
whom were HIV positive and reported high numbers of regular and casual partners, 
chemsex (engaging in sexual activities while under the influence of drugs) and 
meeting sex partners and locating sex parties through social and sexual networking 
[19-21]. The increase in shigellosis has coincided with increasing trends in other 
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sexually transmitted infections among MSM, including lymphogranuloma venereum, 
which have been associated with similar risk behaviours [22-24]. 
We investigated a range of GI pathogens over an 11 year period to explore whether 
the gender distribution would provide signals of potential sexual transmission, 
including known outbreaks among MSM.   
Methods  
Study population 
The study population was residents of England aged 0-65 years, with a laboratory 
confirmed diagnosis of one of 10 GI pathogens of public health significance reported 
to PHE with a specimen date between 1 January 2003 and 31 December 2013, 
known gender and no known history of recent travel. The GI pathogens included 
were: campylobacter, cryptosporidium, Entamoeba histolytica, Giardia spp., hepatitis 
A, norovirus, typhoidal and non-typhoidal salmonellas, shigella, and vero cytotoxin-
producing Escherichia coli (VTEC).  
Data source 
Data were extracted from Labbase, the national laboratory reporting system for 
England until March 2015, which stored data submitted from laboratories throughout 
England, Wales, Northern Ireland and the Channel Islands. For some pathogens - 
including shigella and salmonella - further typing is performed on a subset of 
samples submitted to national reference laboratories and these results supplement 
the Labbase data.  
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Data analysis 
Confirmed laboratory diagnoses for the same pathogen in the same person within a 
2 week period (26 weeks for salmonella) of the earliest specimen were de-duplicated 
and considered as one case-episode, as per established standards used to de-
duplicate Labbase data. This was performed to reduce double counting individuals 
with persisting gastrointestinal infection who have multiple samples taken (e.g. for 
establishing clearance).  
Analyses were restricted to cases resident in England, based on either the postcode 
of the case, general practice or reporting laboratory, in priority order. Cases were 
included if the date of their earliest specimen for a given episode was received by 
the reporting laboratory between 01 January 2003 and 31 December 2013. 
Cases with any known recent foreign travel were excluded from the study. Cases 
were excluded if the laboratory report form noted the case having had any travel to a 
foreign country or listed a travel destination which was outside of the UK prior to 
symptom onset. 
In the primary analysis for each pathogen we examined total and annual percentage 
male and male-to-female ratios for those aged 16-65 years over the study period. 
We made an assumption that in the absence of transmission among MSM by sexual 
contact we would expect 50% of cases to be male, with a 1:1 male-to-female ratio, 
for each pathogen. Binomial exact confidence intervals were calculated for the 
percentage male and a positive signal generated if the lower confidence interval was 
above 50%. We also reviewed data to note where male-to-female ratios rose above 
7 
two, as an arbitrary cut-off as being suggestive of MSM transmission. Chi-squared 
tests for linear trend were applied to assess change in the gender distribution over 
the study period at the 5% level for each pathogen.  
For pathogens with a signal, secondary analyses were undertaken. Comparative 
annual analyses were also conducted by age group (less than 16 years, 16-24 
years, 25-49 years, 50-65 years) and areas with relatively high MSM populations in 
England (London, Brighton and Manchester [25]); termed high risk areas) versus 
elsewhere in England (termed low risk areas) to explore whether the percentage 
male and male-to-female ratio varied with expected differences in the MSM 
population distribution by age group and region. Further investigation of percentage 
male and male-to-female ratios were conducted for shigella species and phage-
types. 
Results 
Over the study period, 529315 GI infection cases were reported in those aged 16-65 
years (Table 1). Of these, 25192 cases (4.8%) were excluded as they reported a 
travel history, leaving 504123 cases aged 16-65 included in the study with no or 
unknown travel history.  
The percentage of cases aged 16-65 years excluded as travel related (4.8%) ranged 
by pathogen from 0.1% for norovirus; (n=18) to 56.9% for typhoidal salmonella 
(n=1959) (Table 1). The percentage of cases classified as having an unknown travel 
history (81%, n=428669) ranged from 36.2% (1247) for typhoidal salmonella to 
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92.2% (n=3358) for hepatitis A. The number of cases included ranged from 1483 for 
typhoidal salmonella to 382641 for campylobacter.
Over the whole 11 year study period combined, a positive signal (a male percentage 
with a lower confidence interval higher than 50%) was observed in adults (16-65 
years) for six out of the 10 pathogens studied (Entamoeba histolytica 68.3% male, 
hepatitis A 61.1%, typhoidal salmonella 55.4%, giardia 54.8%, campylobacter
52.8%, shigella spp. 51.3%) and in three out of four of the shigella species and 
phage-types studied (Table 2). The largest number of excess adult male cases was 
observed for campylobacter (21649) and the highest adult male percentage was 
observed for Shigella flexneri PT3a cases (89.3%). An excess of females was 
observed among adults for cryptosporidium, norovirus, non-typhoidal salmonella,
VTEC and Shigella sonnei. For three of the six pathogens with a male excess in 
adults (Shigella spp., campylobacter and giardia), there was a corresponding male 
excess in children, which was not observed for Entamoeba histolytica, typhoidal 
salmonella, and hepatitis A. For Shigella spp. as a whole, a positive signal was seen 
in high risk areas (62.5% male) but not in low risk areas (44.8%) or in children 
(52.1%). For Shigella flexneri, there was a positive signal for Shigella flexneri in 
adults, in both high (73.7% male) and low risk areas (53.2%), but not in children. For 
Shigella sonnei there was a positive signal in high risk areas (60% male) and in 
children (52.7%) but not in low risk areas (41.9%).  
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When reviewing individual years, no positive signals were observed in any of the 11 
study years for cryptosporidium, norovirus, non-typhoidal salmonella, or VTEC 
(Table 3, Figure 1). 
A positive signal for Shigella spp. in adults first occurred in 2011 with a subsequent 
significant rise (max. 71%, max m:f ratio 2.5), Shigella flexneri from 2010 onwards 
(max. 84.1%, max m:f ratio 5.3) and Shigella sonnei from 2012 (max. 63.5%, max 
m:f ratio 1.7) (Figures 1 and 2, Tables 3 and 4). A stronger signal in adults was seen 
for Shigella flexneri PT2a (max 84.1%, max m:f ratio 5.3) and Shigella flexneri PT3a 
(max 100%, max m:f ratio ∞).  Annual data by age group and location for Shigella 
spp. showed male exceedances being higher, earlier and more frequent in those 
aged 25-49 years than other age groups, and for cases in high risk areas compared 
to low risk areas (Supplementary material S1). No individual year male excess was 
observed for Shigella spp. in children. 
For Entamoeba histolytica a positive signal in adults was observed in all of the 11 
study years for all adults (max. 76.1%, max m:f ratio 3.2), in 10 study years for those 
aged 25-49 years, in three years for those aged 50-65 years, in no years for 16-24 
year olds and once for children (Figure 1, Supplementary material S2). A positive 
signal was observed in nine study years for both high risk and low risk areas.  
A positive signal in adults was observed for hepatitis A in six out of 11 study years 
(max. 69.8%, with a significant falling linear trend at the 5% level) with signals were 
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more frequently observed in cases aged 25-49 years (six years), than those aged 
16-24 years (four) and children (one), and from low risk (seven) compared with high 
risk areas (four) (Figure 1, Table 3, Supplementary material S3).  
For typhoidal salmonella a positive signal in adults was observed in three of the 11 
study years (max. 65.7% with a significant falling trend) and signals were more 
frequently seen in cases aged 25-49 years (three years), than those aged 16-24 
years (none), children (one), and in cases from high risk areas (three) than low risk 
areas (one) (Figure 1, Table 3, Supplementary material S4).  
Positive signals were observed in adults for every year of the study period for 
campylobacter (maximum 53.5%, max m:f ratio 1.1) (Figure 1, Table 3). A signal was 
observed in nearly every year for each age group and every year for low risk areas 
and in nine study years in high risk areas. The percentage male was higher in 
children than in adults. 
For giardia, a positive signal in adults was observed for each of the 11 study years 
(max 57.6%, max m:f ratio 1.4)(Figure 1, Table 3). A signal was more frequently 
observed for adults aged 25-49 years and children (all years), compared to 16-24 
year olds (two years) and 50-65 year olds (one), and in low risk areas (all years) 
compared to high risk areas (ten). 
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For adults aged 15-65 years a male-to-female ratio of cases above an arbitrary cut 
off of two was only observed for Entamoeba histolytica, hepatitis A and Shigella spp. 
for England as a whole (Table 3). For hepatitis A and Entamoeba histolytica there 
were no occasions where the male-to-female ratio was above two and where the 
adult male percentage did not also provide a signal. There was a mixed picture for 
shigella. For Shigella flexneri the male-to-female ratio rose above two in 2012, later 
than the first adult male percentage signal (2010) (Table 4). For Shigella flexneri 
PT2a and PT3a the male-to-female ratio rose above two prior to the adult male 
percentage signal (albeit with small numbers of cases). For Shigella sonnei, the 
male-to-female ratio did not rise above two, while the percentage adult male did 
signal from 2012. 
Discussion 
We have applied analysis of male percentage and male-to-female ratios to 
surveillance data to identify excess gastrointestinal infections among males. This 
approach generated positive signals for excess male episodes for a period with a 
well-characterised increase in shigella among MSM. Positive signals were also 
observed for campylobacter, Entamoeba histolytica, giardia, typhoidal salmonella
and hepatitis A. No signals were detected for cryptosporidium, norovirus, VTEC or 
non-typhoidal salmonella spp. Our analysis suggests that routinely collected national 
surveillance data can be used to help assess the potential contribution of sexual 
exposure to the transmission of GI pathogens and to detect emerging outbreaks in 
MSM. Male excess analysis should be seen as hypothesis generating and any signal 
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detected needs further thorough case level investigation to confirm sexual 
transmission among MSM. 
When using male excess signals among adults to highlight potential MSM 
transmission, other factors that may result in a male excess need to be considered, 
including an excess of males in the population, a reduction in female cases, changes 
in testing and reporting practice, gender specific health seeking behaviour, or 
random variation. Furthermore, other gender disparities in behaviour such as travel, 
childcare, injecting drug use and food consumption may influence exposure to GI 
pathogens such that comparison with a 1:1 male-to-female ratio may not be 
appropriate. However, adult females are more likely to present to primary care than 
adult males likely resulting in a testing bias that would tend to lower the male-to-
female ratio [26]. To strengthen the hypothesis that a signal truly represents an 
increase in MSM sexual transmission, one would expect the signal to be greater in 
adult males aged 25-49 years compared to other age groups, especially children. A 
greater signal in high risk areas may also support the hypothesis for widespread 
MSM sexual transmission contributing to overall cases.   
While we analysed a large national 11 year dataset there were limitations. Recent 
travel history was poorly reported. Inclusion of cases with undocumented travel 
history might lead to misclassification of travel associated infection as domestically 
acquired. The extent and direction of potential bias is difficult to determine and will 
vary by pathogen, as it is dependent on a number of factors, including the proportion 
of cases reporting travel abroad, the proportion of missing travel information, the 
likelihood of sexual transmission while abroad and gender differences in travel 
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abroad. International Passenger Survey (IPS) data for 2013 indicates that UK adult 
males are more likely to travel internationally than females [27] and therefore 
misclassification may lead to an increase in the observed male percentage. 
However, misclassification may result in dilution of effect if a high proportion of 
unknown travel history cases are both likely to be travel related and associated with 
food- or waterborne infection and such exposure is independent of gender. The 
numbers presented here likely underestimate the true counts as not all cases in the 
community present to health care or provide specimens (and the proportion who do 
differ by pathogen) [28]. 
Use of the male-to-female ratio as a marker for MSM activity has been applied 
previously and its usefulness described [6, 18]. Retrospective application of our 
method detected the known increase in S. flexneri PT 2a and 3a and S. sonnei 
among MSM [19, 29], and an outbreak of hepatitis A among MSM in 2004 [30]. 
However, other years in which there was a positive signal for hepatitis A coincided 
with documented outbreaks among people who inject drugs [31, 32], who are over-
represented by young adults and men [33], and the Orthodox Jewish Community 
[34]. Overall, then, our refined approach using age and geographical strata has 
validated the use of male-to-female ratio for highlighting potential MSM transmission. 
The age and geographical distributions of excess male signals for Shigella spp. were 
consistent with MSM-mediated transmission. Signals were more frequently observed 
in areas with large MSM populations and high rates of other sexually transmitted 
infections such as London, Brighton and Manchester, and no signal was seen 
among children. Application of the excess male percentage method to distinct 
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species and age groups appeared to provide more discriminatory power. A signal 
was detected one year earlier both for Shigella spp. in adults aged 25-49 years when 
compared to all adults, and for Shigella flexneri when compared to Shigella spp.. It is 
possible that more signals for other organisms would have been observed with 
further discriminatory typing data.
Among other pathogens with positive signals for male excess cases, Entamoeba 
histolytica and hepatitis A showed the strongest indication of likely MSM 
transmission, with more signals in adults than in children, and for Entamoeba 
histolytica, stronger signals in high risk compared to low risk areas. Transmission 
among MSM has been well described for both these organisms [11-13, 15]. The 
episodic positive signal for typhoidal salmonella may reflect the effect of bias arising 
from incomplete travel information as the majority of cases included in the study with 
no unknown travel were likely to have travelled (57% of typhoidal salmonella cases 
identified were excluded due to known travel and only 7% were known not to have 
travelled).  
The consistent slight male excess of campylobacter and giardia are of interest. The 
burden of campylobacter in England is much greater than other GI infections and 
therefore we found a very high total excess number of adult males over the study 
period. Transmission among MSM have been described for both campylobacter [3, 
4] and giardia [6, 7], however, the finding for both organisms that the excess is 
consistent in individual years, in both children and adults, and in low as well as high 
risk areas may mean that gender factors other than sexual transmission are 
important in explaining the male excess among adults in this study. Campylobacter 
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infections in England and Wales have previously been reported to be more common 
in men up until 15 years and thereafter more common in women [35],  and in a study 
among English residents of Pakistani origin with campylobacter infection, a higher 
proportion were males [36].  
We analysed both the percentage male (applying confidence intervals) and the male-
to-female ratio. The sensitivity of using an arbitrary male-to-female ratio threshold 
e.g. two, to trigger action is greatly influenced by the number of cases due to other 
transmission routes for each pathogen. In our study the number of campylobacter
cases was much higher than shigella cases and for a given number of cases due to 
sexual transmission among MSM, the male-to-female ratio would be higher for 
shigella than campylobacter. In addition, the baseline male-to-female ratio in the 
absence of sexual transmission appears to differ by pathogen e.g. the 
cryptosporidium male-to-female ratio consistently remained below one. Given these 
factors, pathogen specific threshold ratios which trigger action could be refined, 
modelled on historical data. 
In our study we excluded all known travel related cases, prioritising identifying 
domestic sexual transmission. However, MSM may acquire infections due to sexual 
activity abroad and this method could be refined for each organism to include travel 
to destinations where it was considered that sexual transmission may be more likely 
than other transmission routes e.g. via food or water.  
Monitoring gender differences can be seen as a supplementary approach to existing 
measures. Traditional outbreak detection methods e.g. weekly statistical exceedance 
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of total counts compared to expected values determined from recent years, may 
detect outbreaks due to MSM transmission, when subsequent descriptive 
epidemiology points to an excess of adult males. However, there are a number of 
reasons why MSM outbreaks may be more likely to go undetected than food-borne 
outbreaks. The person to person nature of MSM transmission (as opposed to point 
source food-borne outbreaks) may result in a rising tide of cases over many months 
and therefore may be less to likely trigger weekly exceedances. Furthermore, food-
borne outbreaks may be detected due to sick diners recognising a common event 
and approaching authorities. In contrast, MSM may incorrectly ascribe their illness 
due to food poisoning and therefore it is less likely that links to sexual transmission 
events will be reported. A foodborne outbreak may also result in subsequent MSM 
transmission and so periodic review of gender difference for known prolonged 
outbreaks may help identify a change in transmission route.  
There is growing evidence that transmission of GI pathogens among MSM is 
becoming a public health concern globally, especially among HIV-positive MSM 
reporting high risk sexual and drug use behaviours [16, 17, 37-39].  In England, 
outbreaks of Shigella flexneri, have been associated with high rates of hospitalisation 
and reports of bacteraemia [20, 21]. More recently, there has been an increase in the 
male-to-female ratio of Shigella sonnei cases [29], characterised clusters of 
extended spectrum beta-lactamase producing Shigella sonnei [40], vero cytotoxin-
producing Escherichia coli O117:H7 among (mostly HIV-positive) MSM [5] and an 
international outbreak of hepatitis A [14]. Simple methods to improve detection of 
outbreaks of GI pathogens that may lead to severe health outcomes are therefore 
needed. In the absence of routinely collected information on sexual orientation, 
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routine application of this rapid method, refined to use pathogen specific male-to-
female ratio or percentage male thresholds at the most granular typing discrimination 
available, might be a useful tool to alert public health authorities to potential GI 
infection outbreaks associated with sexual contact among MSM and afford earlier 
health promotion and interventions. We recommend that this approach be used by 
other countries to detect excess male cases and prompt further investigations to 
assess whether sexual transmission of GI pathogens among MSM warrants public 
health action. Surveillance could be further improved by introducing simple questions 
on recent sexual exposure in routine questionnaires for GI pathogens.   
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Table 1. Laboratory confirmed gastrointestinal infection cases aged 16-65 years by recent travel 
status for pathogens, England, 2003-2013  
Organism 
Known travel 
related (%) 
Known not 
travel related 
(%) Unknown (%) 
Total known not 
travel related or 
unknown (%) Total 
Campylobacter spp. 658 (0.2) 50,506 (13.2) 332,135 (86.7) 382,641 (99.8) 383,299 
Cryptosporidium spp. 470 (2.6) 2,573 (14) 15,334 (83.4) 17,907 (97.4) 18,377 
Entamoeba histolytica 333 (17.4) 126 (6.6) 1,455 (76) 1,581 (82.6) 1,914 
Giardia spp. 1,473 (5.6) 3,389 (12.9) 21,387 (81.5) 24,776 (94.4) 26,249 
Hepatitis A 78 (2.1) 206 (5.7) 3,358 (92.2) 3,564 (97.9) 3,642 
Norovirus 18 (0.1) 1,290 (10.2) 11,348 (89.7) 12,638 (99.9) 12,656
Salmonella spp. (non-
typhoidal) 17,794 (27.9) 14,871 (23.3) 31,039 (48.7) 45,910 (72.1) 63,704 
Salmonella spp (typhoidal) 1,959 (56.9) 236 (6.9) 1,247 (36.2) 1,483 (43.1) 3,442 
Shigella spp. 1,709 (14) 1,498 (12.3) 9,008 (73.7) 10,506 (86) 12,215 
     Shigella flexneri 450 (14) 462 (14.4) 2,291 (71.5) 2753 (86) 3,203 
     Shigella sonnei 1,047 (14.5) 844 (11.7) 5,327 (73.8) 6,171 (85.5) 7,218 
     Shigella flexneri PT2a 88 (27.3) 63 (19.6) 171 (53.1) 234 (72.7) 322 
     Shigella flexneri PT3a 66 (16.3) 116 (28.7) 222 (55) 338 (83.7) 404 
VTEC 700 (18.3) 759 (19.9) 2,358 (61.8) 3,117 (81.7) 3,817 
Total 25,192 (4.8) 75,454 (14.3) 428,669 (81.0) 504,123 (95.2) 529,315
Table 2. Excess number of male cases, male-to-female ratio and percentage male by pathogen, risk area and age group, for laboratory 
confirmed gastrointestinal infections with no reported travel history, England, 2003-2013. 
Organism 
Total 
cases 16-
65 yrs 
No. excess 
males 16-
65 yrs 
Male-to-female 
ratio in 16-65 
yrs 
% Male 
16-65 yrs all areas 16-65 yrs in high risk areas 
16-65 yrs in low 
risk areas  < 16 yrs 
Campylobacter spp. 382,641 21,649 1.12 52.8 (52.7-53.0) 52.1 (51.6-52.6) 52.9 (52.8-53.1) 60.3 (60.0-60.7) 
Cryptosporidium spp. 17,907 -4,643 0.59 37.0 (36.3-37.7) 45.8 (43.1-48.6) 36.4 (35.6-37.1) 56.5 (55.9-57.2) 
Entamoeba histolytica 1,581 579 2.16 68.3 (65.9-70.6) 74.4 (70.9-77.6) 63.5 (60.3-66.7) 58.4 (48.8-67.6) 
Giardia spp. 24,776 2,396 1.21 54.8 (54.2-55.5) 58.5 (56.9-60.1) 54.2 (53.5-54.9) 58.2 (56.9-59.4) 
Hepatitis A 3,564 792 1.57 61.1 (59.5-62.7) 54.0 (51.0-57.1) 64.0 (62.1-65.9) 51.8 (48.3-55.2) 
Norovirus 12,638 -858 0.87 46.6 (45.7-47.5) 52.5 (49.0-56.0) 46.2 (45.3-47.1) 56.0 (54.9-57.2) 
Salmonella spp. (non-
typhoidal) 45,910 -816 0.97 49.1 (48.7-49.6) 48.8 (47.8-49.8) 49.2 (48.7-49.7) 53.1 (52.5-53.8) 
Salmonella spp. 
(typhoidal) 1,483 161 1.24 55.4 (52.9-58.0) 56.4 (52.8-59.9) 54.4 (50.6-58.1) 53.6 (48.9-58.3) 
Shigella spp. 10,506 272 1.05 51.3 (50.3-52.3) 62.5 (60.9-64.0) 44.8 (43.6-46.0) 52.1 (50.2-54.0) 
     S. flexneri 2753 651 1.62 61.8 (60.0-63.6) 73.7 (71.1-76.3) 53.2 (50.7-55.7) 50.2 (46.8-53.6) 
     S.  sonnei 6,171 -261 0.92 47.9 (46.6-49.1) 60.0 (57.9-62.2) 41.9 (40.4-43.5) 52.7 (50.1-55.3) 
     S.  flexneri PT2a 234 102 2.55 71.8 (65.6-77.5) 86.4 (78.5-92.2) 58.9 (49.7-67.6) 44.0 (33.2-55.3) 
     S. flexneri PT3a 338 266 8.39 89.3 (85.6-92.4) 99.0 (96.3-99.9) 85.9 (78.7-91.4) 34.2 (19.6-51.4) 
VTEC 3,117 -673 0.64 39.2 (37.5-40.9) 35.5 (30.0-41.3) 39.6 (37.8-41.4) 51.4 (49.8-53.1) 
Total 504,123 18,859
Ratios above a threshold of two or where the percentage male has a lower confidence interval above 50% are shaded. 
Table 3. Cases aged 16 to 65 years diagnosed with certain gastrointestinal infections with no reported travel history, by sex, male-to-female ratio 
and percentage male, England, 2003-2013 (n=504,123) 
Organism 
Sex, m:f 
ratio and 
percentage 
male 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Total p value†
Campylobacter 
spp. Female 14,559 13,981 14,986 14,451 15,713 14,929 17,552 18,977 19,295 18,934 17,119 180,496 0.114
Male 16,250 15,910 16,386 16,287 17,587 16,720 19,127 21,067 21,572 21,509 19,730 202,145
Ratio 1.1 1.1 1.1 1.1 1.1 1.1 1.1 1.1 1.1 1.1 1.2 1.1
Percentage 
(95% CI) 
52.7 
(52.2-
53.3)
53.2 
(52.7-
53.8) 
52.2 
(51.7-
52.8)
53.0 
(52.4-
53.5) 
52.8 
(52.3-
53.4)
52.8 
(52.3-
53.4) 
52.1 
(51.6-
52.7) 
52.6 
(52.1-
53.1)
52.8 
(52.3-
53.3) 
53.2 
(52.7-
53.7)
53.5 
(53.0-
54.1) 
52.8 
(52.7-
53)
Cryptosporidium 
spp. Female 1,109 793 957 921 812 1,041 1,211 1,011 721 1,690 1,009 11,275 0.259
Male 674 539 532 565 471 600 627 585 462 979 598 6,632
Ratio 0.6 0.7 0.6 0.6 0.6 0.6 0.5 0.6 0.6 0.6 0.6 0.6
Percentage 
(95% CI) 
37.8 
(35.5-
40.1)
40.5 
(37.8-
43.2) 
35.7 
(33.3-
38.2)
38.0 
(35.5-
40.5) 
36.7 
(34.1-
39.4)
36.6 
(34.2-
38.9) 
34.1 
(31.9-
36.3) 
36.7 
(34.3-
39.1)
39.1 
(36.3-
41.9) 
36.7 
(34.8-
38.5)
37.2 
(34.8-
39.6) 
37.0 
(36.3-
37.7)
Entamoeba 
histolytica Female 56 71 61 48 33 51 29 30 34 56 32 501 0.365
Male 134 150 135 110 77 76 70 53 108 104 63 1,080
Ratio 2.4 2.1 2.2 2.3 2.3 1.5 2.4 1.8 3.2 1.9 2.0* 2.2
Percentage 
(95% CI) 
70.5 
(63.5-
76.9)
67.9 
(61.3-
74) 
68.9 
(61.9-
75.3)
69.6 
(61.8-
76.7) 
70 
(60.5-
78.4)
59.8 
(50.8-
68.4) 
70.7 
(60.7-
79.4) 
63.9 
(52.6-
74.1)
76.1 
(68.2-
82.8) 
65 
(57.1-
72.4)
66.3 
(55.9-
75.7) 
68.3 (66-
70.6)
Giardia spp. Female 923 899 876 875 905 1039 1080 1163 1144 1180 1106 11,190 <0.001
Male 1250 1219 1097 1058 1102 1226 1227 1317 1390 1418 1282 13,586
Ratio 1.4 1.4 1.3 1.2 1.2 1.2 1.1 1.1 1.2 1.2 1.2 1.2
Percentage 
(95% CI) 
57.5 
(55.4-
59.6)
57.6 
(55.4-
59.7) 
55.6 
(53.4-
57.8)
54.7 
(52.5-
57) 
54.9 
(52.7-
57.1)
54.1 
(52-
56.2) 
53.2 
(51.1-
55.2) 
53.1 
(51.1-
55.1)
54.9 
(52.9-
56.8) 
54.6 
(52.6-
56.5)
53.7 
(51.7-
55.7) 
54.8 
(54.2-
55.5)
Hepatitis A Female 244 135 98 84 159 260 140 65 52 66 83 1,386 <0.001
Male 537 283 227 159 159 285 151 141 82 88 66 2,178
Ratio 2.2 2.1 2.3 1.9 1.0 1.1 1.1 2.2 1.6 1.3 0.8 1.6
Percentage 
(95% CI) 
68.8 
(65.4-
72)
67.7 
(63-
72.2) 
69.8 
(64.5-
74.8)
65.4 
(59.1-
71.4) 
50.0 
(44.4-
55.6)
52.3 
(48-
56.6) 
51.9 
(46-
57.8) 
68.4 
(61.6-
74.7)
61.2 
(52.4-
69.5) 
57.1 
(48.9-
65.1)
44.3 
(36.2-
52.7) 
61.1 
(59.5-
62.7)
Norovirus Female 237 343 289 411 577 652 802 1,077 761 919 680 6,748 0.001
Male 195 259 217 355 461 526 670 980 683 920 624 5,890
Ratio 0.8 0.8 0.8 0.9 0.8 0.8 0.8 0.9 0.9 1.0 0.9 0.9
Percentage 
(95% CI) 
45.1 
(40.4-
50)
43.0 
(39.0-
47.1) 
42.9 
(38.5-
47.3)
46.3 
(42.8-
49.9) 
44.4 
(41.4-
47.5)
44.7 
(41.8-
47.5) 
45.5 
(42.9-
48.1) 
47.6 
(45.5-
49.8)
47.3 
(44.7-
49.9) 
50.0 
(47.7-
52.3)
47.9 
(45.1-
50.6) 
46.6 
(45.7-
47.5)
Salmonella spp.
(non-typhoidal) Female 3,393 3,092 2,446 2,770 2,610 1,824 1,703 1,407 1,489 1,380 1,249 23,363 0.032
Male 3,213 3,197 2,434 2,648 2,467 1,732 1,763 1,335 1,335 1,244 1,179 22,547
Ratio 0.9 1.0 1.0 1.0 0.9 0.9 1.0 0.9 0.9 0.9 0.9 1.0
Percentage 
(95% CI) 
48.6 
(47.4-
49.9)
50.8 
(49.6-
52.1) 
49.9 
(48.5-
51.3)
48.9 
(47.5-
50.2) 
48.6 
(47.2-
50.0)
48.7 
(47.1-
50.4) 
50.9 
(49.2-
52.5) 
48.7 
(46.8-
50.6)
47.3 
(45.4-
49.1) 
47.4 
(45.5-
49.3)
48.6 
(46.6-
50.6) 
49.1 
(48.7-
49.6)
Salmonella spp. 
(typhoidal) Female 36 54 54 68 73 83 71 60 72 44 46 661 0.038
Male 69 55 76 100 84 100 87 91 74 41 45 822
Ratio 1.9 1.0 1.4 1.5 1.2 1.2 1.2 1.5 1.0 0.9 1.0 1.2
Percentage 
(95% CI) 
65.7 
(55.8-
74.7)
50.5 
(40.7-
60.2) 
58.5 
(49.5-
67.0)
59.5 
(51.7-
67.0) 
53.5 
(45.4-
61.5)
54.6 
(47.1-
62.0) 
55.1 
(47.0-
63) 
60.3 
(52.0-
68.1)
50.7 
(42.3-
59.0) 
48.2 
(37.3-
59.3)
49.5 
(38.8-
60.1) 
55.4 
(52.9-
58.0)
Shigella spp. Female 342 410 510 447 608 527 612 611 434 314 302 5117 <0.001
Male 273 413 400 319 450 457 465 649 582 640 741 5389
Ratio 0.8 1.0 0.8 0.7 0.7 0.9 0.8 1.1 1.3 2.0 2.5 1.1
Percentage 
(95% CI) 
44.4 
(40.4-
48.4)
50.2 
(46.7-
53.7) 
44 
(40.7-
47.3)
41.6 
(38.1-
45.2) 
42.5 
(39.5-
45.6)
46.4 
(43.3-
49.6) 
43.2 
(40.2-
46.2) 
51.5 
(48.7-
54.3)
57.3 
(54.2-
60.3) 
67.1 
(64-
70.1)
71 
(68.2-
73.8) 
51.3 
(50.3-
52.3)
VTEC Female 73 120 154 223 193 170 208 159 257 148 190 1895 0.412
Male 64 71 83 131 134 107 118 112 152 115 135 1222
Ratio 0.9 0.6 0.5 0.6 0.7 0.6 0.6 0.7 0.6 0.8 0.7 0.6
Percentage 
(95% CI) 
46.7 
(38.1-
55.4)
37.2 
(30.3-
44.4) 
35.0 
(29.0-
41.5)
37.0 
(32.0-
42.3) 
41.0 
(35.6-
46.5)
38.6 
(32.9-
44.6) 
36.2 
(31.0-
41.7) 
41.3 
(35.4-
47.4)
37.2 
(32.5-
42.0) 
43.7 
(37.6-
50.0)
41.5 
(36.1-
47.1) 
39.2 
(37.5-
40.9)
†Chi-squared test for linear trend; CI, Confidence Interval; *Met threshold on rounding up. 
Ratios above a threshold of two or where the percentage male has a lower confidence interval above 50% are shaded. 
Table 4. Cases aged 16 to 65 years diagnosed with Shigella flexneri and Shigella sonnei infections with no reported travel history, by sex, male-
to-female ratio and percentage male for selected serotypes, England, 2003–2013  
Organism Serotype 
Sex,m:f
ratio and 
percentage 
male 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Total p value†
Shigella 
flexneri All Female 77 88 97 95 112 102 110 121 107 76 66 1,051 <0.001 
Male 65 73 92 95 101 121 137 204 208 257 349 1,702
Ratio 0.8 0.8 0.9 1.0 0.9 1.2 1.2 1.7 1.9 3.4 5.3 1.6
Percentage 
(95% CI) 
45.8 
(37.4-
54.3)
45.3 
(37.5-
53.4) 
48.7 
(41.4-
56.0)
50.0 
(42.7-
57.3)
47.4 
(40.6-
54.4) 
54.3 
(47.5-
60.9) 
55.5 
(49.0-
61.8)
62.8 
(57.3-
68.0)
66 
(60.5-
71.2)
77.2 
(72.3-
81.6) 
84.1 
(80.2-
87.5) 
61.8 
(60.0-
63.6)
PT 2a Female 4 7 4 4 2 4 3 3 7 14 14 66 <0.001 
Male 3 2 5 4 0 4 7 6 21 42 74 168
Ratio 0.8 0.3 1.3 1.0 0.0 1.0 2.3 2.0 3.0 3.0 5.3 2.5
Percentage 
(95% CI) 
42.9 
(9.9-
81.6)
22.2 
(2.8-
60.0) 
55.6 
(21.2-
86.3)
50.0 
(15.7-
84.3)
0 (0-
84.2) 
50.0 
(15.7-
84.3) 
70.0 
(34.8-
93.3)
66.7 
(29.9-
92.5)
75.0 
(55.1-
89.3)
75.0 
(61.6-
85.6) 
84.1 
(74.8-
91) 
71.8 
(65.6-
77.5)
PT 3a Female 3 0 2 1 0 2 1 0 1 11 15 36 <0.001 
Male 2 1 1 0 7 4 4 8 23 82 170 302
Ratio 0.7 ∞ 0.5 0.0 ∞ 2.0 4.0 ∞ 23.0 7.5 11.3 8.4
Percentage 
(95% CI) 
40.0 
(5.3-
85.3)
100 
(2.5-
100) 
33.3 
(0.8-
90.6)
0 (0-
97.5)
100 
(59.0-
100) 
66.7 
(22.3-
95.7) 
80 
(28.4-
99.5)
100 
(63.1-
100)
95.8 
(78.9-
99.9)
88.2 
(79.8-
93.9) 
91.9 
(87-
95.4) 
89.3 
(85.6-
92.4)
Shigella 
sonnei  All Female 212 253 326 271 387 304 414 409 261 184 195 3,216 <0.001 
Male 162 271 262 163 274 247 264 365 295 320 332 2,955
Ratio 0.8 1.1 0.8 0.6 0.7 0.8 0.6 0.9 1.1 1.7 1.7 0.9
Percentage 
(95% CI) 
43.3 
(38.2-
48.5)
51.7 
(47.3-
56.1) 
44.6 
(40.5-
48.7)
37.6 
(33-
42.3)
41.5 
(37.7-
45.3) 
44.8 
(40.6-
49.1) 
38.9 
(35.2-
42.7)
47.2 
(43.6-
50.7)
53.1 
(48.8-
57.3)
63.5 
(59.1-
67.7) 
63 
(58.7-
67.1) 
47.9 
(46.6-
49.1)
†Chi-squared test for linear trend; CI, Confidence Interval. 
Ratios above a threshold of two or where the percentage male has a lower confidence interval above 50% are shaded. 
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Epidemiology and Infection: Use of gender distribution in routine surveillance data to detect potential transmission of gastrointestinal infections 
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S 1. Cases aged 16 to 65 years diagnosed with Shigella spp. infection with no reported travel history, by sex, male-to-female ratio and 
percentage male for age groups and high and low-risk locations, England, 2003–2013  
Age group  
or location 
Sex, m:f ratio & 
percent-age male 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Total 
p 
value†
<16 years Female 107 114 124 105 123 133 122 145 132 125 99 1329 0.388
Male 99 134 125 120 124 150 130 159 158 130 118 1447
Ratio 0.9 1.2 1.0 1.1 1.0 1.1 1.1 1.1 1.2 1.0 1.2 1.1
Percentage (95% 
CI) 
48.1 
(41.1-
55.1)
54 
(47.6-
60.4)
50.2 
(43.8-
56.6)
53.3 
(46.6-
60.0)
50.2 
(43.8-
56.6)
53.0 
(47.0-
58.9)
51.6 
(45.2-
57.9) 
52.3 
(46.5-
58)
54.5 
(48.6-
60.3)
51.0 
(44.7-
57.3)
54.4 
(47.5-
61.1)
52.1 
(50.2-
54)
16-24 years Female 50 90 88 78 108 80 137 117 74 42 53 917 <0.001
Male 44 43 52 29 71 71 54 63 63 69 76 635.0
Ratio 0.9 0.5 0.6 0.4 0.7 0.9 0.4 0.5 0.9 1.6 1.4 0.7
Percentage (95% 
CI) 
46.8 
(36.4-
57.4)
32.3 
(24.5-
41)
37.1 
(29.1-
45.7)
27.1 
(19.0-
36.6)
39.7 
(32.4-
47.2)
47.0 
(38.9-
55.3)
28.3 
(22.0-
35.2) 
35.0 
(28.1-
42.4)
46.0 
(37.4-
54.7)
62.2 
(52.5-
71.2)
58.9 
(49.9-
67.5)
40.9 
(38.5-
43.4)
25-49 years Female 224 236 310 278 366 317 349 335 256 199 186 3056 <0.001
Male 186 265 269 208 280 270 324 454 393 475 541 3665
Ratio 0.8 1.1 0.9 0.7 0.8 0.9 0.9 1.4 1.5 2.4 2.9 1.2
Percentage (95% 
CI) 
45.4 
(40.5-
50.3)
52.9 
(48.4-
57.3)
46.5 
(42.3-
50.6)
42.8 
(38.4-
47.3)
43.3 
(39.5-
47.3)
46.0 
(41.9-
50.1)
48.1 
(44.3-
52.0) 
57.5 
(54.0-
61.0)
60.6 
(56.7-
64.3)
70.5 
(66.9-
73.9)
74.4 
(71.1-
77.6)
54.5 
(53.3-
55.7)
50-65 years Female 68 84 112 91 134 130 126 159 104 73 63 1144 <0.001
Male 43 105 79 82 99 116 87 132 126 96 124 1089
Ratio 0.6 1.3 0.7 0.9 0.7 0.9 0.7 0.8 1.2 1.3 2.0* 1.0
Percentage (95% 
CI) 
38.7 
(29.6-
48.5)
55.6 
(48.2-
62.8)
41.4 
(34.3-
48.7)
47.4 
(39.8-
55.1)
42.5 
(36.1-
49.1)
47.2 
(40.8-
53.6)
40.8 
(34.2-
47.8) 
45.4 
(39.5-
51.3)
54.8 
(48.1-
61.3)
56.8 
(49.0-
64.4)
66.3 
(59.1-
73.0)
48.8 
(46.7-
50.9)
 Brighton, 
London or 
Manchester 
Female 92 116 136 112 147 147 166 136 149 124 117 1442 <0.001
Male 107 174 125 111 155 161 194 277 270 359 470 2403
Ratio 1.2 1.5 0.9 1.0 1.1 1.1 1.2 2.0 1.8 2.9 4.0 1.7
Percentage (95% 
CI) 
53.8 
(46.6-
60.8)
60 
(54.1-
65.7)
47.9 
(41.7-
54.1)
49.8 
(43.0-
56.5)
51.3 
(45.5-
57.1)
52.3 
(46.5-
58.0)
53.9 
(48.6-
59.1) 
67.1 
(62.3-
71.6)
64.4 
(59.6-
69.0)
74.3 
(70.2-
78.2)
80.1 
(76.6-
83.2)
62.5 
(60.9-
64)
Other 
location 
Female 250 294 374 335 461 380 446 475 285 190 185 3675 <0.001
Male 166 239 275 208 295 296 271 372 312 281 271 2986
Ratio 0.7 0.8 0.7 0.6 0.6 0.8 0.6 0.8 1.1 1.5 1.5 0.8
Percentage (95% 
CI) 
39.9 
(35.2-
44.8)
44.8 
(40.6-
49.2)
42.4 
(38.5-
46.3)
38.3 
(34.2-
42.5)
39.0 
(35.5-
42.6)
43.8 
(40.0-
47.6)
37.8 
(34.2-
41.5) 
43.9 
(40.5-
47.3)
52.3 
(48.2-
56.3)
59.7 
(55.1-
64.1)
59.4 
(54.8-
64.0)
44.8 
(43.6-
46)
†Chi-squared test for linear trend; CI, Confidence Interval; *Met threshold on rounding up. 
Ratios above a threshold of two or where the percentage male has a lower confidence interval above 50% are shaded. 
S 2. Cases aged 16 to 65 years diagnosed with Entamoeba histolytica infection with no reported travel history, by sex, male-to-female ratio and 
percentage male for age groups and high and low-risk locations, England, 2003–2013  
Age group  
or location 
Sex, m:f ratio & 
percentage male 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Total 
p 
value†
<16 years Female 9 3 2 3 6 2 4 3 4 7 4 47 0.325
Male 6 3 5 5 4 12 5 7 9 8 2 66
Ratio 0.7 1.0 2.5 1.7 0.7 6.0 1.3 2.3 2.3 1.1 0.5 1.4
Percentage (95% CI) 
40.0 
(16.3-
67.7)
50.0 
(11.8-
88.2) 
71.4 
(29.0-
96.3)
62.5 
(24.5-
91.5) 
40.0 
(12.2-
73.8)
85.7 
(57.2-
98.2) 
55.6 
(21.2-
86.3)
70.0 
(34.8-
93.3)
69.2 
(38.6-
90.9) 
53.3 
(26.6-
78.7)
33.3 
(4.3-
77.7) 
58.4 
(48.8-
67.6)
16-24 years Female 13 13 11 4 5 9 3 8 6 11 3 86 0.86
Male 12 12 13 8 6 7 7 6 10 14 7 102.0
Ratio 0.9 0.9 1.2 2.0 1.2 0.8 2.3 0.8 1.7 1.3 2.3 1.2
Percentage (95% CI) 
48.0 
(27.8-
68.7)
48.0 
(27.8-
68.7) 
54.2 
(32.8-
74.4)
66.7 
(34.9-
90.1) 
54.5 
(23.4-
83.3)
43.8 
(19.8-
70.1) 
70.0 
(34.8-
93.3)
42.9 
(17.7-
71.1)
62.5 
(35.4-
84.8) 
56.0 
(34.9-
75.6)
70.0 
(34.8-
93.3) 
54.3 
(46.8-
61.5)
25-49 years Female 35 44 38 30 18 38 20 19 21 35 20 318 0.313
Male 102 114 93 87 55 57 49 37 68 70 37 769
Ratio 2.9 2.6 2.4 2.9 3.1 1.5 2.5 1.9 3.2 2.0 1.9 2.4
Percentage (95% CI) 
74.5 
(66.3-
81.5)
72.2 
(64.5-
79) 
71.0 
(62.4-
78.6)
74.4 
(65.5-
82) 
75.3 
(63.9-
84.7)
60.0 
(49.4-
69.9) 
71.0 
(58.8-
81.3)
66.1 
(52.2-
78.2)
76.4 
(66.2-
84.8) 
66.7 
(56.8-
75.6)
64.9 
(51.1-
77.1) 
70.7 
(67.9-
73.4)
50-65 years Female 8 14 12 14 10 4 6 3 7 10 9 97 0.574
Male 20 24 29 15 16 12 14 10 30 20 19 209
Ratio 2.5 1.7 2.4 1.1 1.6 3.0 2.3 3.3 4.3 2.0 2.1 2.2
Percentage (95% CI) 
71.4 
(51.3-
86.8)
63.2 
(46.0-
78.2) 
70.7 
(54.5-
83.9)
51.7 
(32.5-
70.6) 
61.5 
(40.6-
79.8)
75.0 
(47.6-
92.7) 
70.0 
(45.7-
88.1)
76.9 
(46.2-
95)
81.1 
(64.8-
92) 
66.7 
(47.2-
82.7)
67.9 
(47.6-
84.1) 
68.3 
(62.8-
73.5)
Brighton. 
London or 
Manchester 
Female 27 30 40 10 4 8 7 12 12 19 10 179 0.132
Male 76 88 88 70 22 24 25 20 41 43 22 519
Ratio 2.8 2.9 2.2 7.0 5.5 3.0 3.6 1.7 3.4 2.3 2.2 2.9
Percentage (95% CI) 
73.8 
(64.2-
82.0)
74.6 
(65.7-
82.1) 
68.8 
(60.0-
76.6)
87.5 
(78.2-
93.8) 
84.6 
(65.1-
95.6)
75.0 
(56.6-
88.5) 
78.1 
(60.0-
90.7)
62.5 
(43.7-
78.9)
77.4 
(63.8-
87.7) 
69.4 
(56.3-
80.4)
68.8 
(50.0-
83.9) 
74.4 
(70.9-
77.6)
Other location Female 29 41 21 38 29 43 22 18 22 37 22 322 0.100
Male 58 62 47 40 55 52 45 33 67 61 41 561
Ratio 2.0 1.5 2.2 1.1 1.9 1.2 2.0 1.8 3.0 1.6 1.9 1.7
Percentage (95% CI) 
66.7 
(55.7-
76.4)
60.2 
(50.1-
69.7) 
69.1 
(56.7-
79.8)
51.3 
(39.7-
62.8) 
65.5 
(54.3-
75.5)
54.7 
(44.2-
65.0) 
67.2 
(54.6-
78.2)
64.7 
(50.1-
77.6)
75.3 
(65.0-
83.8) 
62.2 
(51.9-
71.8)
65.1 
(52.0-
76.7) 
63.5 
(60.3-
66.7)
†Chi-squared test for linear trend; CI, Confidence Interval.Ratios above a threshold of two or where the percentage male has a lower confidence interval above 50% are 
shaded. 
S3. Cases aged 16 to 65 years diagnosed with Hepatitis A infection with no reported travel history, by sex, male-to-female ratio and percentage 
male for age groups and high and low-risk locations, England, 2003–2013  
Age group  or 
location 
Sex, m:f ratio & 
percentage male 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Total 
p
value†
<16 years Female 82 49 28 50 26 37 19 33 26 28 33 411 0.635
Male 79 53 37 39 27 36 40 44 30 31 25 441
Ratio 1.0 1.1 1.3 0.8 1.0 1.0 2.1 1.3 1.2 1.1 0.8 1.1
Percentage (95% 
CI) 
49.1 
(41.1-
57.1)
52.0 
(41.8-
62.0)
56.9 
(44.0-
69.2)
43.8 
(33.3-
54.7)
50.9 
(36.8-
64.9) 
49.3 
(37.4-
61.3)
67.8 
(54.4-
79.4)
57.1 
(45.4-
68.4)
53.6 
(39.7-
67.0) 
52.5 
(39.1-
65.7)
43.1 
(30.2-
56.8)
51.8 
(48.3-
55.2)
16-24 years Female 93 37 22 21 26 49 31 21 12 12 22 346 <0.001
Male 205 52 43 46 27 52 38 33 17 25 11 549.0
Ratio 2.2 1.4 2.0* 2.2 1.0 1.1 1.2 1.6 1.4 2.1 0.5 1.6
Percentage (95% 
CI) 
68.8 
(63.2-
74.0)
58.4 
(47.5-
68.8)
66.2 
(53.4-
77.4)
68.7 
(56.2-
79.4)
50.9 
(36.8-
64.9) 
51.5 
(41.3-
61.6)
55.1 
(42.6-
67.1)
61.1 
(46.9-
74.1)
58.6 
(38.9-
76.5) 
67.6 
(50.2-
82.0)
33.3 
(18.0-
51.8)
61.3 
(58.1-
64.5)
25-49 years Female 119 67 45 40 98 165 73 27 27 37 40 738 <0.001
Male 289 188 141 79 105 182 83 80 46 43 42 1278
Ratio 2.4 2.8 3.1 2.0* 1.1 1.1 1.1 3.0 1.7 1.2 1.1 1.7
Percentage (95% 
CI) 
70.8 
(66.2-
75.2)
73.7 
(67.9-
79.0)
75.8 
(69-
81.8)
66.4 
(57.2-
74.8)
51.7 
(44.6-
58.8) 
52.4 
(47.0-
57.8)
53.2 
(45.1-
61.2)
74.8 
(65.4-
82.7)
63.0 
(50.9-
74.0) 
53.8 
(42.2-
65.0)
51.2 
(39.9-
62.4)
63.4 
(61.2-
65.5)
50-65 years Female 32 31 31 23 35 46 36 17 13 17 21 302 0.143
Male 43 43 43 34 27 51 30 28 19 20 13 351
Ratio 1.3 1.4 1.4 1.5 0.8 1.1 0.8 1.6 1.5 1.2 0.6 1.2
Percentage (95% 
CI) 
57.3 
(45.4-
68.7)
58.1 
(46.1-
69.5)
58.1 
(46.1-
69.5)
59.6 
(45.8-
72.4)
43.5 
(31.0-
56.7) 
52.6 
(42.2-
62.8)
45.5 
(33.1-
58.2)
62.2 
(46.5-
76.2)
59.4 
(40.6-
76.3) 
54.1 
(36.9-
70.5)
38.2 
(22.2-
56.4)
53.8 
(49.8-
57.6)
Brighton. 
London or 
Manchester 
Female 18 18 14 14 68 197 59 12 21 21 36 478 0.001
Male 49 37 38 25 52 191 53 36 27 24 30 562
Ratio 2.7 2.1 2.7 1.8 0.8 1.0 0.9 3.0 1.3 1.1 0.8 1.2
Percentage (95% 
CI) 
73.1 
(60.9-
83.2)
67.3 
(53.3-
79.3)
73.1 
(59-
84.4)
64.1 
(47.2-
78.8)
43.3 
(34.3-
52.7) 
49.2 
(44.1-
54.3)
47.3 
(37.8-
57.0)
75.0 
(60.4-
86.4)
56.3 
(41.2-
70.5) 
53.3 
(37.9-
68.3)
45.5 
(33.1-
58.2)
54.0
(51.0-
57.1)
Other location Female 226 117 84 70 91 63 81 53 31 45 47 908 <0.001
Male 488 246 189 134 107 94 98 105 55 64 36 1616
Ratio 2.2 2.1 2.3 1.9 1.2 1.5 1.2 2.0* 1.8 1.4 0.8 1.8
Percentage (95% 
CI) 
68.3 
(64.8-
71.7)
67.8 
(62.7-
72.6)
69.2 
(63.4-
74.7)
65.7 
(58.7-
72.2)
54.0 
(46.8-
61.1) 
59.9 
(51.8-
67.6)
54.7 
(47.2-
62.2)
66.5 
(58.5-
73.8)
64.0 
(52.9-
74.0) 
58.7 
(48.9-
68.1)
43.4 
(32.5-
54.7)
64.0 
(62.1-
65.9)
†Chi-squared test for linear trend; CI, Confidence Interval; *Met threshold on rounding up. 
Ratios above a threshold of two or where the percentage male has a lower confidence interval above 50% are shaded. 
S 4. Cases aged 16 to 65 years diagnosed with typhoidal Salmonella spp. infection with no reported travel history, by sex, male-to-female ratio 
and percentage male for age groups and high and low-risk locations, England, 2003–2013  
Age group  or 
location 
Sex, m:f ratio & 
percentage male 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Total 
p 
value†
<16 years Female 19 14 16 21 21 20 43 21 22 11 4 212 0.373
Male 23 21 24 19 42 22 22 31 18 13 10 245
Ratio 1.2 1.5 1.5 0.9 2.0 1.1 0.5 1.5 0.8 1.2 2.5 1.2
Percentage (95% 
CI) 
54.8 
(38.7-
70.2)
60 
(42.1-
76.1) 
60 
(43.3-
75.1)
47.5 
(31.5-
63.9) 
66.7 
(53.7-
78.0)
52.4 
(36.4-
68.0) 
33.8 
(22.6-
46.6)
59.6 
(45.1-
73.0)
45 
(29.3-
61.5) 
54.2 
(32.8-
74.4)
71.4 
(41.9-
91.6) 
53.6 
(48.9-
58.3)
16-24 years Female 11 13 12 13 17 21 19 20 17 11 13 167 0.073
Male 23 12 17 20 26 25 24 29 20 7 8 211
Ratio 2.1 0.9 1.4 1.5 1.5 1.2 1.3 1.5 1.2 0.6 0.6 1.3
Percentage (95% 
CI) 
67.6 
(49.5-
82.6)
48 
(27.8-
68.7) 
58.6 
(38.9-
76.5)
60.6 
(42.1-
77.1) 
60.5 
(44.4-
75.0)
54.3 
(39.0-
69.1) 
55.8 
(39.9-
70.9)
59.2 
(44.2-
73.0)
54.1 
(36.9-
70.5) 
38.9 
(17.3-
64.3)
38.1 
(18.1-
61.6) 
55.8 
(50.7-
60.9)
25-49 years Female 21 30 37 43 45 50 39 33 43 24 25 390 0.463
Male 38 34 51 72 46 65 54 55 47 30 31 523
Ratio 1.8 1.1 1.4 1.7 1 1.3 1.4 1.7 1.1 1.3 1.2 1.3
Percentage (95% 
CI) 
64.4 
(50.9-
76.4)
53.1 
(40.2-
65.7) 
58.0 
(47.0-
68.4)
62.6 
(53.1-
71.5) 
50.5 
(39.9-
61.2)
56.5 
(47.0-
65.7) 
58.1 
(47.4-
68.2)
62.5 
(51.5-
72.6)
52.2 
(41.4-
62.9) 
55.6 
(41.4-
69.1)
55.4 
(41.5-
68.7) 
57.3 
(54.0-
60.5)
50-65 years Female 4 11 5 12 11 12 13 7 12 9 8 104 0.114
Male 8 9 8 8 12 10 9 7 7 4 6 88
Ratio 2 0.8 1.6 0.7 1.1 0.8 0.7 1 0.6 0.4 0.8 0.8
Percentage (95% 
CI) 
66.7 
(34.9-
90.1)
45.0 
(23.1-
68.5) 
61.5 
(31.6-
86.1)
40.0 
(19.1-
63.9) 
52.2 
(30.6-
73.2)
45.5 
(24.4-
67.8) 
40.9 
(20.7-
63.6)
50.0 
(23.0-
77.0)
36.8 
(16.3-
61.6) 
30.8 
(9.1-
61.4)
42.9 
(17.7-
71.1) 
45.8 
(38.6-
53.2)
Brighton. 
London or 
Manchester 
Female 20 31 19 39 40 44 31 34 38 26 21 343 0.199
Male 41 31 39 45 41 62 36 58 47 19 24 443
Ratio 2.1 1 2.1 1.2 1 1.4 1.2 1.7 1.2 0.7 1.1 1.3
Percentage (95% 
CI) 
67.2 
(54.0-
78.7)
50.0 
(37.0-
63.0) 
67.2 
(53.7-
79.0)
53.6 
(42.4-
64.5) 
50.6 
(39.3-
61.9)
58.5 
(48.5-
68.0) 
53.7 
(41.1-
66.0)
63.0 
(52.3-
72.9)
55.3 
(44.1-
66.1) 
42.2 
(27.7-
57.8)
53.3 
(37.9-
68.3) 
56.4 
(52.8-
59.9)
Other location Female 16 23 35 29 33 39 40 26 34 18 25 318 0.094
Male 28 24 37 55 43 38 51 33 27 22 21 379
Ratio 1.8 1 1.1 1.9 1.3 1 1.3 1.3 0.8 1.2 0.8 1.2
Percentage (95% 
CI) 
63.6 
(47.8-
77.6)
51.1 
(36.1-
65.9) 
51.4 
(39.3-
63.3)
65.5 
(54.3-
75.5) 
56.6 
(44.7-
67.9)
49.4 
(37.8-
61.0) 
56.0 
(45.2-
66.4)
55.9 
(42.4-
68.8)
44.3 
(31.5-
57.6) 
55.0 
(38.5-
70.7)
45.7 
(30.9-
61.0) 
54.4 
(50.6-
58.1)
†Chi-squared test for linear trend; CI, Confidence Interval. 
Ratios above a threshold of two or where the percentage male has a lower confidence interval above 50% are shaded. 
